Evaluation of Response to Induction Therapy in Breast Cancer With Phosphorus-31 Magnetic Resonance Spectroscopy

Abstract

The objective of the proposed research is to develop 1H-decoupled 31P magnetic resonance spectroscopy (MRS) techniques for measuring non-invasively the response of breast cancer to induction or preoperative chemotherapy. We hypothesize that the quantitative assessment of the effectiveness of a treatment using 31P MRS will be clinically feasible at 3.OT. Although the hardware modifications made to the MR scanner to enable 31P MRS were completed, and a breast RF coil was constructed and tested successfully, significant delays in the delivery of the scanner and in the manufacturer providing scanner software to properly operate at the phosphorus frequency resulted in poor progress. Patient scanning was not achieved. It is expected that some patients will be scanned in the near future using another source of funding in order to complete the goals of the study.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Aug 01, 2003
Accession Number
ADA426058

Entities

People

  • Jerome L. Ackerman

Organizations

  • Massachusetts General Hospital

Tags

Communities of Interest

  • Advanced Electronics
  • Biomedical
  • Energy and Power Technologies

DTIC Thesaurus Topics

  • Acquisition
  • Biomedical Research
  • Breast Cancer
  • Cancer
  • Chemotherapy
  • Drug Therapy
  • Frequency
  • Magnetic Resonance
  • Neoplasms
  • Phosphorus
  • Radio Frequency Power
  • Resonance
  • Scanners
  • Scanning
  • Spectra
  • Spectral Lines
  • Spectroscopy

Fields of Study

  • Medicine

Readers

  • Geodesy
  • Oncology
  • Software Engineering